| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |